CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

As a longtime business owner in North Carolina and someone who’s worked closely with employers across the hospitality and ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Bob Powell: Well, Wegovy can no longer be used for weight loss reasons under Medicare. And here to talk with me about that is Jae Oh, author of Maximize Your Medicare.

Generally, Medicare does not cover certain medications, such as glucagon-like peptide-1 (GLP-1) receptor agonists, for treating weight loss alone. That said, this may be changing.

The injectable drugs have exploded in popularity due to the potentially life-changing weight loss that some patients experience.

Medicare currently covers drugs that are used for weight loss, like Mounjaro and Ozempic, but only when they are prescribed by doctors for other reasons like managing diabetes. Drugs like Novo ...

Medicare already covers drugs that are also widely used for weight loss, like Ozempic and Mounjaro, when they are prescribed by doctors for other reasons like managing diabetes.

The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's Wegovy.

Medicare, the government insurance program for Americans over 65 and people with disabilities, does cover the weight-loss drugs for patients with diabetes, and for a much smaller subset of people ...

Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are likely to decline starting in 2027, thanks to their inclusion on a list of medicines whose prices will be ...